Fieldpoint Private Securities’s Novartis NVS Stock Holding History

Fieldpoint Private Securities’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$475K	Sell	5,624 -914	-14%	-$80.2K	0.14%	159
2022 Q1	$574K	Buy	6,538 +643	+11%	+$55.7K	0.12%	185
2021 Q4	$516K	Buy	5,895 +360	+7%	+$29.9K	0.1%	203
2021 Q3	$453K	Buy	5,535 +138	+3%	+$12.4K	0.1%	211
2021 Q2	$498K	Buy	5,397 +245	+5%	+$21.8K	0.11%	201
2021 Q1	$440K	Buy	5,152 +5	+0.1%	+$449	0.1%	209
2020 Q4	$486K	Sell	5,147 -3,777	-42%	-$330K	0.11%	191
2020 Q3	$776K	Buy	8,924 +1,718	+24%	+$149K	0.23%	120
2020 Q2	$629K	Buy	7,206 +2,861	+66%	+$247K	0.21%	126
2020 Q1	$359K	Buy	4,345 +375	+9%	+$33.5K	0.14%	159
2019 Q4	$376K	Buy	3,970 +550	+16%	+$49.4K	0.11%	188
2019 Q3	$297K	Hold	3,420	–	–	0.11%	183
2019 Q2	$312K	Buy	3,420 +239	+8%	+$20.2K	0.1%	195
2019 Q1	$274K	Hold	3,181	–	–	0.11%	168
2018 Q4	$245K	Sell	3,181 -279	-8%	-$21.7K	0.11%	174
2018 Q3	$267K	Sell	3,460 -223	-6%	-$16.5K	0.1%	184
2018 Q2	$249K	Hold	3,683	–	–	0.1%	189
2018 Q1	$267K	Sell	3,683 -446	-11%	-$34K	0.12%	146
2017 Q4	$311K	Sell	4,129 -1,068	-21%	-$80.6K	0.16%	128
2017 Q3	$400K	Buy	5,197 +1,068	+26%	+$80.7K	0.17%	129
2017 Q2	$309K	Hold	4,129	–	–	0.21%	55
2017 Q1	$275K	Buy	+4,129	New	+$275K	0.21%	86

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fieldpoint Private Securities's NVS Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Novartis (NVS) stake by 14% in Q2 2022, selling an estimated $80.2K and leaving 5,624 shares worth $475K. The position accounts for 0.14% of the portfolio, ranked #159.

Fieldpoint Private Securities first reported a position in NVS in Q1 2017 and has held it in 22 quarters since. The position peaked at $776K in Q3 2020. 1,141 funds tracked by Wall St. Rank hold NVS as of Q2 2022.

Fieldpoint Private Securities held 5,624 shares of Novartis worth $475K as of Q2 2022.
Fieldpoint Private Securities sold 914 Novartis shares in Q2 2022, an estimated $80.2K.
Novartis made up 0.14% of Fieldpoint Private Securities's portfolio in Q2 2022, its #159 holding.
Fieldpoint Private Securities first reported a position in Novartis in Q1 2017 and has held it in 22 quarters since.
Fieldpoint Private Securities's Novartis position peaked at $776K in Q3 2020.
1,141 funds tracked by Wall St. Rank held Novartis as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.